Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
7.13
+0.11 (1.57%)
Dec 5, 2025, 5:00 PM CET
-38.64%
Market Cap 115.24M
Revenue (ttm) 14.81M
Net Income (ttm) -59.30M
Shares Out 16.16M
EPS (ttm) -3.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 61,160
Average Volume 30,833
Open 7.00
Previous Close 7.02
Day's Range 6.98 - 7.24
52-Week Range 6.95 - 11.80
Beta 0.40
RSI 25.57
Earnings Date Nov 25, 2025

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services. In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation o... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.